Dafna Capital Management LLC Kal Vista Pharmaceuticals, Inc. Transaction History
Dafna Capital Management LLC
- $389 Million
- Q3 2024
A detailed history of Dafna Capital Management LLC transactions in Kal Vista Pharmaceuticals, Inc. stock. As of the latest transaction made, Dafna Capital Management LLC holds 723,678 shares of KALV stock, worth $6.48 Million. This represents 2.15% of its overall portfolio holdings.
Number of Shares
723,678
Previous 806,973
10.32%
Holding current value
$6.48 Million
Previous $9.51 Million
11.85%
% of portfolio
2.15%
Previous 2.44%
Shares
20 transactions
Others Institutions Holding KALV
# of Institutions
125Shares Held
47.8MCall Options Held
551KPut Options Held
110K-
Vr Adviser, LLC New York, NY6.25MShares$56 Million7.5% of portfolio
-
Tang Capital Management LLC San Diego, CA4.32MShares$38.7 Million4.26% of portfolio
-
Suvretta Capital Management, LLC New York, NY4.21MShares$37.7 Million1.92% of portfolio
-
Vestal Point Capital, LP New York, NY4MShares$35.8 Million3.51% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.69MShares$33 Million2.3% of portfolio
About KalVista Pharmaceuticals, Inc.
- Ticker KALV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,602,000
- Market Cap $220M
- Description
- KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...